HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Beecham Corp.

Division of GlaxoSmithKline PLC

Latest From SmithKline Beecham Corp.

As Expected: Shareholders Back Bristol's $74bn Celgene Buy

With no more activist investor challenge, shareholders of both companies overwhelmingly approved the deal. Bristol said it will have leading positions in oncology and cardiovascular disease, and gain five potential blockbusters in the Celgene buyout.

Deals Business Strategies

Supreme Court’s Pro-Pharma Decision On Sales Rep Overtime Reproves Informal Agency Policymaking

Court rules that reps’ nonbinding commitments from physicians to prescribe drugs constitute a sale and thus make them outside sales employees who are exempt from overtime. Court also rebukes Labor Department’s policy change outside of rulemaking.

BioPharmaceutical Legal Issues

Supreme Court Attacks Dept. Of Labor Actions In Sales Rep Overtime Case

The high court questioned the nature of pharmaceutical sales rep work and what constitutes a sale in the case Christopher v. SmithKline Beecham; Justice Stephen Breyer asked GSK’s attorney what the court should say in crafting an opinion.

BioPharmaceutical Legal Issues

Supreme Court Attacks Dept. of Labor Actions In Sales Rep Overtime Case

The high court questioned the nature of pharmaceutical sales rep work and what constitutes a sale in the case Christopher v. SmithKline Beecham; Justice Stephen Breyer asked GSK’s attorney what the court should say in crafting an opinion.

BioPharmaceutical Legal Issues
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Jan Leschly, CEO
    Hugh R Collum, CFO,Group Fin.Dir.
    John Saunders, SVP,Corp. Dev.
    George Poste, PhD, DSc, SVP,R&D
  • Contact Info
  • SmithKline Beecham Corp.
    Phone: (215) 751-4000
    1 Franklin Plaza
    Philadelphia, PA 19101
    USA
UsernamePublicRestriction

Register